Correlation Between Pfizer and Taro Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Taro Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Taro Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Taro Pharmaceutical Industries, you can compare the effects of market volatilities on Pfizer and Taro Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Taro Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Taro Pharmaceutical.

Diversification Opportunities for Pfizer and Taro Pharmaceutical

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Pfizer and Taro is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Taro Pharmaceutical Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taro Pharmaceutical and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Taro Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taro Pharmaceutical has no effect on the direction of Pfizer i.e., Pfizer and Taro Pharmaceutical go up and down completely randomly.

Pair Corralation between Pfizer and Taro Pharmaceutical

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Taro Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.48 times less risky than Taro Pharmaceutical. The stock trades about -0.07 of its potential returns per unit of risk. The Taro Pharmaceutical Industries is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  2,915  in Taro Pharmaceutical Industries on August 28, 2024 and sell it today you would earn a total of  1,382  from holding Taro Pharmaceutical Industries or generate 47.41% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy77.1%
ValuesDaily Returns

Pfizer Inc  vs.  Taro Pharmaceutical Industries

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Taro Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taro Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Taro Pharmaceutical is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pfizer and Taro Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Taro Pharmaceutical

The main advantage of trading using opposite Pfizer and Taro Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Taro Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taro Pharmaceutical will offset losses from the drop in Taro Pharmaceutical's long position.
The idea behind Pfizer Inc and Taro Pharmaceutical Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Global Correlations
Find global opportunities by holding instruments from different markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum